Europe Recombinant Antibody Market Research Report Forecast 2017-2021

April 2017 | 117 pages | ID: EE50E37653AEN
S&P Consulting

Abstracts

The Europe Recombinant Antibody Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Recombinant Antibody industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Recombinant Antibody market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Recombinant Antibody Market Analysis by Countries :
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
A.G.Scientific
Abbott Diagnostics
Agilent Technologies
BD Biosciences
Beckman Coulter
bioMerieux
Bio-Rad Laboratories
F. Hoffmann-La Roche
Gallus Immunotech

Europe Recombinant Antibody Market Analysis by Product :
Type 1
Type 2
Type 3

Europe Recombinant Antibody Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 RECOMBINANT ANTIBODY MARKET OVERVIEW

1.1 Product Overview and Scope of Recombinant Antibody
1.2 Classification of Recombinant Antibody
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Recombinant Antibody
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Recombinant Antibody Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Recombinant Antibody (2012-2021)
  1.5.1 Europe Recombinant Antibody Sales and Growth Rate (2012-2021)
  1.5.2 Europe Recombinant Antibody Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON RECOMBINANT ANTIBODY INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 RECOMBINANT ANTIBODY MANUFACTURING COST ANALYSIS

3.1 Recombinant Antibody Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Recombinant Antibody

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Recombinant Antibody Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE RECOMBINANT ANTIBODY MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Recombinant Antibody Market Competition by Manufacturers
  5.1.1 Europe Recombinant Antibody Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Recombinant Antibody Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Recombinant Antibody (Volume and Value) by Type
  5.2.1 Europe Recombinant Antibody Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Recombinant Antibody Revenue and Market Share by Type (2012-2017)
5.3 Europe Recombinant Antibody (Volume and Value) by Countries
  5.3.1 Europe Recombinant Antibody Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Recombinant Antibody Revenue and Market Share by Countries (2012-2017)
5.4 Europe Recombinant Antibody (Volume) by Application

6 GERMANY RECOMBINANT ANTIBODY (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Recombinant Antibody Sales and Value (2012-2017)
  6.1.1 Germany Recombinant Antibody Sales and Growth Rate (2012-2017)
  6.1.2 Germany Recombinant Antibody Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Recombinant Antibody Sales Price Trend (2012-2017)
6.2 Germany Recombinant Antibody Sales and Market Share by Manufacturers
6.3 Germany Recombinant Antibody Sales and Market Share by Type
6.4 Germany Recombinant Antibody Sales and Market Share by Application

7 FRANCE RECOMBINANT ANTIBODY (VOLUME, VALUE AND SALES PRICE)

7.1 France Recombinant Antibody Sales and Value (2012-2017)
  7.1.1 France Recombinant Antibody Sales and Growth Rate (2012-2017)
  7.1.2 France Recombinant Antibody Revenue and Growth Rate (2012-2017)
  7.1.3 France Recombinant Antibody Sales Price Trend (2012-2017)
7.2 France Recombinant Antibody Sales and Market Share by Manufacturers
7.3 France Recombinant Antibody Sales and Market Share by Type
7.4 France Recombinant Antibody Sales and Market Share by Application

8 UK RECOMBINANT ANTIBODY (VOLUME, VALUE AND SALES PRICE)

8.1 UK Recombinant Antibody Sales and Value (2012-2017)
  8.1.1 UK Recombinant Antibody Sales and Growth Rate (2012-2017)
  8.1.2 UK Recombinant Antibody Revenue and Growth Rate (2012-2017)
  8.1.3 UK Recombinant Antibody Sales Price Trend (2012-2017)
8.2 UK Recombinant Antibody Sales and Market Share by Manufacturers
8.3 UK Recombinant Antibody Sales and Market Share by Type
8.4 UK Recombinant Antibody Sales and Market Share by Application

9 RUSSIA RECOMBINANT ANTIBODY (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Recombinant Antibody Sales and Value (2012-2017)
  9.1.1 Russia Recombinant Antibody Sales and Growth Rate (2012-2017)
  9.1.2 Russia Recombinant Antibody Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Recombinant Antibody Sales Price Trend (2012-2017)
9.2 Russia Recombinant Antibody Sales and Market Share by Manufacturers
9.3 Russia Recombinant Antibody Sales and Market Share by Type
9.4 Russia Recombinant Antibody Sales and Market Share by Application

10 ITALY RECOMBINANT ANTIBODY (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Recombinant Antibody Sales and Value (2012-2017)
  10.1.1 Italy Recombinant Antibody Sales and Growth Rate (2012-2017)
  10.1.2 Italy Recombinant Antibody Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Recombinant Antibody Sales Price Trend (2012-2017)
10.2 Italy Recombinant Antibody Sales and Market Share by Manufacturers
10.3 Italy Recombinant Antibody Sales and Market Share by Type
10.4 Italy Recombinant Antibody Sales and Market Share by Application

11 SPAIN RECOMBINANT ANTIBODY (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Recombinant Antibody Sales and Value (2012-2017)
  11.1.1 Spain Recombinant Antibody Sales and Growth Rate (2012-2017)
  11.1.2 Spain Recombinant Antibody Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Recombinant Antibody Sales Price Trend (2012-2017)
11.2 Spain Recombinant Antibody Sales and Market Share by Manufacturers
11.3 Spain Recombinant Antibody Sales and Market Share by Type
11.4 Spain Recombinant Antibody Sales and Market Share by Application

12 BENELUX RECOMBINANT ANTIBODY (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Recombinant Antibody Sales and Value (2012-2017)
  12.1.1 Benelux Recombinant Antibody Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Recombinant Antibody Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Recombinant Antibody Sales Price Trend (2012-2017)
12.2 Benelux Recombinant Antibody Sales and Market Share by Manufacturers
12.3 Benelux Recombinant Antibody Sales and Market Share by Type
12.4 Benelux Recombinant Antibody Sales and Market Share by Application

13 EUROPE RECOMBINANT ANTIBODY MANUFACTURERS ANALYSIS

13.1 A.G.Scientific
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Abbott Diagnostics
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Agilent Technologies
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 BD Biosciences
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Beckman Coulter
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 bioMerieux
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Bio-Rad Laboratories
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 F. Hoffmann-La Roche
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Gallus Immunotech
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE RECOMBINANT ANTIBODY MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Recombinant Antibody Market Forecast by Type (2017-2021)
15.9 Europe Recombinant Antibody Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Antibody
Table Classification of Recombinant Antibody
Figure Europe Sales Market Share of Recombinant Antibody by Type in 2015
Table Application of Recombinant Antibody
Figure Europe Sales Market Share of Recombinant Antibody by Application in 2015
Figure Germany Recombinant Antibody Revenue and Growth Rate (2012-2021)
Figure France Recombinant Antibody Revenue and Growth Rate (2012-2021)
Figure UK Recombinant Antibody Revenue and Growth Rate (2012-2021)
Figure Russia Recombinant Antibody Revenue and Growth Rate (2012-2021)
Figure Italy Recombinant Antibody Revenue and Growth Rate (2012-2021)
Figure Spain Recombinant Antibody Revenue and Growth Rate (2012-2021)
Figure Benelux Recombinant Antibody Revenue and Growth Rate (2012-2021)
Figure Europe Recombinant Antibody Sales and Growth Rate (2012-2021)
Figure Europe Recombinant Antibody Revenue and Growth Rate (2012-2021)
Table Europe Recombinant Antibody Sales of Key Manufacturers (2015 and 2016)
Table Europe Recombinant Antibody Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Antibody Sales Share by Manufacturers
Figure 2016 Recombinant Antibody Sales Share by Manufacturers
Table Europe Recombinant Antibody Revenue by Manufacturers (2015 and 2016)
Table Europe Recombinant Antibody Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Recombinant Antibody Revenue Share by Manufacturers
Table 2016 Europe Recombinant Antibody Revenue Share by Manufacturers
Table Europe Recombinant Antibody Sales and Market Share by Type (2012-2017)
Table Europe Recombinant Antibody Sales Share by Type (2012-2017)
Figure Sales Market Share of Recombinant Antibody by Type (2012-2017)
Figure Europe Recombinant Antibody Sales Growth Rate by Type (2012-2017)
Table Europe Recombinant Antibody Revenue and Market Share by Type (2012-2017)
Table Europe Recombinant Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Antibody by Type (2012-2017)
Figure Europe Recombinant Antibody Revenue Growth Rate by Type (2012-2017)
Table Europe Recombinant Antibody Sales and Market Share by Countries (2012-2017)
Table Europe Recombinant Antibody Sales Share by Countries (2012-2017)
Figure Sales Market Share of Recombinant Antibody by Countries (2012-2017)
Table Europe Recombinant Antibody Revenue and Market Share by Countries (2012-2017)
Table Europe Recombinant Antibody Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Recombinant Antibody by Countries (2012-2017)
Table Europe Recombinant Antibody Sales and Market Share by Application (2012-2017)
Table Europe Recombinant Antibody Sales Share by Application (2012-2017)
Figure Sales Market Share of Recombinant Antibody by Application (2012-2017)
Figure Germany Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure Germany Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure Germany Recombinant Antibody Sales Price Trend (2012-2017)
Table Germany Recombinant Antibody Sales by Manufacturers (2015 and 2016)
Table Germany Recombinant Antibody Market Share by Manufacturers (2015 and 2016)
Table Germany Recombinant Antibody Sales by Type (2015 and 2016)
Table Germany Recombinant Antibody Market Share by Type (2015 and 2016)
Table Germany Recombinant Antibody Sales by Application (2015 and 2016)
Table Germany Recombinant Antibody Market Share by Application (2015 and 2016)
Figure France Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure France Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure France Recombinant Antibody Sales Price Trend (2012-2017)
Table France Recombinant Antibody Sales by Manufacturers (2015 and 2016)
Table France Recombinant Antibody Market Share by Manufacturers (2015 and 2016)
Table France Recombinant Antibody Sales by Type (2015 and 2016)
Table France Recombinant Antibody Market Share by Type (2015 and 2016)
Table France Recombinant Antibody Sales by Application (2015 and 2016)
Table France Recombinant Antibody Market Share by Application (2015 and 2016)
Figure UK Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure UK Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure UK Recombinant Antibody Sales Price Trend (2012-2017)
Table UK Recombinant Antibody Sales by Manufacturers (2015 and 2016)
Table UK Recombinant Antibody Market Share by Manufacturers (2015 and 2016)
Table UK Recombinant Antibody Sales by Type (2015 and 2016)
Table UK Recombinant Antibody Market Share by Type (2015 and 2016)
Table UK Recombinant Antibody Sales by Application (2015 and 2016)
Table UK Recombinant Antibody Market Share by Application (2015 and 2016)
Figure Russia Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure Russia Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure Russia Recombinant Antibody Sales Price Trend (2012-2017)
Table Russia Recombinant Antibody Sales by Manufacturers (2015 and 2016)
Table Russia Recombinant Antibody Market Share by Manufacturers (2015 and 2016)
Table Russia Recombinant Antibody Sales by Type (2015 and 2016)
Table Russia Recombinant Antibody Market Share by Type (2015 and 2016)
Table Russia Recombinant Antibody Sales by Application (2015 and 2016)
Table Russia Recombinant Antibody Market Share by Application (2015 and 2016)
Figure Italy Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure Italy Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure Italy Recombinant Antibody Sales Price Trend (2012-2017)
Table Italy Recombinant Antibody Sales by Manufacturers (2015 and 2016)
Table Italy Recombinant Antibody Market Share by Manufacturers (2015 and 2016)
Table Italy Recombinant Antibody Sales by Type (2015 and 2016)
Table Italy Recombinant Antibody Market Share by Type (2015 and 2016)
Table Italy Recombinant Antibody Sales by Application (2015 and 2016)
Table Italy Recombinant Antibody Market Share by Application (2015 and 2016)
Figure Spain Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure Spain Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure Spain Recombinant Antibody Sales Price Trend (2012-2017)
Table Spain Recombinant Antibody Sales by Manufacturers (2015 and 2016)
Table Spain Recombinant Antibody Market Share by Manufacturers (2015 and 2016)
Table Spain Recombinant Antibody Sales by Type (2015 and 2016)
Table Spain Recombinant Antibody Market Share by Type (2015 and 2016)
Table Spain Recombinant Antibody Sales by Application (2015 and 2016)
Table Spain Recombinant Antibody Market Share by Application (2015 and 2016)
Figure Benelux Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure Benelux Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure Benelux Recombinant Antibody Sales Price Trend (2012-2017)
Table Benelux Recombinant Antibody Sales by Manufacturers (2015 and 2016)
Table Benelux Recombinant Antibody Market Share by Manufacturers (2015 and 2016)
Table Benelux Recombinant Antibody Sales by Type (2015 and 2016)
Table Benelux Recombinant Antibody Market Share by Type (2015 and 2016)
Table Benelux Recombinant Antibody Sales by Application (2015 and 2016)
Table Benelux Recombinant Antibody Market Share by Application (2015 and 2016)
Table A.G.Scientific Basic Information List
Table A.G.Scientific Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure A.G.Scientific Recombinant Antibody Sales Market Share (2012-2017)
Table Abbott Diagnostics Basic Information List
Table Abbott Diagnostics Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Diagnostics Recombinant Antibody Sales Market Share (2012-2017)
Table Agilent Technologies Basic Information List
Table Agilent Technologies Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Agilent Technologies Recombinant Antibody Sales Market Share (2012-2017)
Table BD Biosciences Basic Information List
Table BD Biosciences Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table BD Biosciences Recombinant Antibody Sales Market Share (2012-2017)
Table Beckman Coulter Basic Information List
Table Beckman Coulter Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Beckman Coulter Recombinant Antibody Sales Market Share (2012-2017)
Table bioMerieux Basic Information List
Table bioMerieux Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table bioMerieux Recombinant Antibody Sales Market Share (2012-2017)
Table Bio-Rad Laboratories Basic Information List
Table Bio-Rad Laboratories Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bio-Rad Laboratories Recombinant Antibody Sales Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche Recombinant Antibody Sales Market Share (2012-2017)
Table Gallus Immunotech Basic Information List
Table Gallus Immunotech Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gallus Immunotech Recombinant Antibody Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Antibody
Figure Manufacturing Process Analysis of Recombinant Antibody
Figure Recombinant Antibody Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2015
Table Major Buyers of Recombinant Antibody
Table Distributors/Traders List
Figure Germany Recombinant Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Germany Recombinant Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure France Recombinant Antibody Sales and Growth Rate Forecast (2017-2021)
Figure France Recombinant Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure UK Recombinant Antibody Sales and Growth Rate Forecast (2017-2021)
Figure UK Recombinant Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Recombinant Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Russia Recombinant Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Recombinant Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Italy Recombinant Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Recombinant Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Spain Recombinant Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Recombinant Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Recombinant Antibody Revenue and Growth Rate Forecast (2017-2021)
Table Europe Recombinant Antibody Sales Forecast by Type (2017-2021)
Table Europe Recombinant Antibody Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

A.G.Scientific
Abbott Diagnostics
Agilent Technologies
BD Biosciences
Beckman Coulter
bioMerieux
Bio-Rad Laboratories
F. Hoffmann-La Roche
Gallus Immunotech
GE Healthcare
Lonza Biologics Ltd
Merck KGaA
Meridian Life Science